NCT01258868 2019-12-03Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasNational Institutes of Health Clinical Center (CC)Phase 1 Terminated44 enrolled